STOCK COMMENTS / EPS CHANGESAlere ( ALR) estimates, price target were reduced at Wedbush. Shares are now seen reaching $23. FDA concerns are leading to higher manufacturing costs, Wedbush said. Neutral rating. Delta ( DAL) was added to the US 1 List at Bank of America/Merrill Lynch. Industry fundamentals are strong, and the company is cutting cost, BofA/Merrill said. Buy rating. Dick's Sporting Goods ( DKS) price target was raised at UBS to $56. Encouraging data points for the first quarter. Buy rating. JP Morgan ( JPM) numbers were lowered at Citigroup. Shares are now seen reaching $45. Estimates were also lowered on $2 billion hit, and damage to reputation. Buy rating. Medicis ( MRX) numbers were raised at Jefferies. Shares are now seen reaching $49. Estimates were also raised on the biggest upside report in recent memory, Jefferies said. Buy rating. Netsuite ( N) was added to the Conviction Buy List at Goldman Sachs. The stock is attractive, following a 16% decline, Goldman said. $55 price target. NVIDIA Corp. price target was lowered at Jefferies. Shares are now seen reaching $15. First-quarter beat with upside surprise, Jefferies said. Hold rating. Children's Place ( PLCE) was added to US 1 List at BofA/Merrill. Comp sales are at an inflection point, and the company should see higher margins, BofA/Merrill said. Synchronoss ( SNCR) was cut from the Conviction Buy List at Goldman Sachs. Expect slower growth from AT&T ( T) channel, Goldman said. $28 price target. Molson Coors ( TAP) estimates were cut at Morgan Stanley through 2013. Volumes remain weak, and the company is facing margin pressure, Morgan Stanley said. Equal-weight rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.